Literature DB >> 15023873

Shed membrane particles from T lymphocytes impair endothelial function and regulate endothelial protein expression.

Sophie Martin1, Angela Tesse, Bénédicte Hugel, M Carmen Martínez, Olivier Morel, Jean-Marie Freyssinet, Ramaroson Andriantsitohaina.   

Abstract

BACKGROUND: Microparticles (MPs) are membrane vesicles with procoagulant and proinflammatory properties released during cell activation. The present study was designed to dissect the effects evoked by T lymphocyte-derived MPs on vascular function. METHODS AND
RESULTS: MPs were produced by treatment of the human lymphoid CEM T cell line with actinomycin D or phytohemagglutinin. Incubation of mouse aortic rings with 30 nmol/L MPs resulted in a time-dependent impairment of acetylcholine-induced relaxation of precontracted vessels, with a maximal reduction after 24 hours. MPs also impaired shear stress-induced dilatation of mouse small mesenteric arteries by affecting the nitric oxide (NO) and prostacyclin but not the endothelium-derived hyperpolarizing factor components of the response. However, neither alteration of calcium signaling in response to agonists nor reduction of cyclooxygenase-1 expression accounted for the impairment of the NO and prostacyclin components of the endothelial response. The effect of MPs was rather because of a decrease in expression of endothelial NO synthase and an overexpression of caveolin-1. Furthermore, lymphocyte-derived MPs from diabetic patients or in vivo circulating MPs from either diabetic or HIV-infected patients reduced endothelial NO synthase expression. Finally, the effects of MPs on endothelial cells were not driven through CD11a/CD18 adhesion molecules or the Fas/FasL pathway.
CONCLUSIONS: MPs from T cells induce endothelial dysfunction in both conductance and resistance arteries by alteration of NO and prostacyclin pathways. MPs regulate protein expression for endothelial NO synthase and caveolin-1. These data contribute to a better understanding of the deleterious effects of enhanced circulating MPs observed in disorders with cardiovascular or immune complications.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15023873     DOI: 10.1161/01.CIR.0000124065.31211.6E

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  64 in total

1.  Sphingosine-1-phosphate receptor-3 is a novel biomarker in acute lung injury.

Authors:  Xiaoguang Sun; Patrick A Singleton; Eleftheria Letsiou; Jing Zhao; Patrick Belvitch; Saad Sammani; Eddie T Chiang; Liliana Moreno-Vinasco; Michael S Wade; Tong Zhou; Bin Liu; Ioannis Parastatidis; Leonor Thomson; Harry Ischiropoulos; Viswanathan Natarajan; Jeffrey R Jacobson; Roberto F Machado; Steven M Dudek; Joe G N Garcia
Journal:  Am J Respir Cell Mol Biol       Date:  2012-07-05       Impact factor: 6.914

2.  Circulating Extracellular Vesicles in Normotension Restrain Vasodilation in Resistance Arteries.

Authors:  Miranda E Good; Luca Musante; Sabrina La Salvia; Nancy L Howell; Robert M Carey; Thu H Le; Brant E Isakson; Uta Erdbrügger
Journal:  Hypertension       Date:  2019-11-25       Impact factor: 10.190

3.  Microparticles in endothelial cell and vascular homeostasis: are they really noxious?

Authors:  Olivier Morel; Florence Toti; Nicolas Morel; Jean-Marie Freyssinet
Journal:  Haematologica       Date:  2009-03       Impact factor: 9.941

4.  Thalassemic erythrocytes release microparticles loaded with hemichromes by redox activation of p72Syk kinase.

Authors:  Emanuela Ferru; Antonella Pantaleo; Franco Carta; Franca Mannu; Amina Khadjavi; Valentina Gallo; Luisa Ronzoni; Giovanna Graziadei; Maria Domenica Cappellini; Francesco Turrini
Journal:  Haematologica       Date:  2013-09-13       Impact factor: 9.941

Review 5.  Role of microparticles in endothelial dysfunction and arterial hypertension.

Authors:  Thomas Helbing; Christoph Olivier; Christoph Bode; Martin Moser; Philipp Diehl
Journal:  World J Cardiol       Date:  2014-11-26

6.  Generation of lymphocytic microparticles and detection of their proapoptotic effect on airway epithelial cells.

Authors:  Chun Yang; Wei Xiong; Qian Qiu; Houda Tahiri; Carmen Gagnon; Guoxiang Liu; Pierre Hardy
Journal:  J Vis Exp       Date:  2015-02-20       Impact factor: 1.355

Review 7.  Microparticles and cardiovascular diseases.

Authors:  Christos Voukalis; Eduard Shantsila; Gregory Y H Lip
Journal:  Ann Med       Date:  2019-06-17       Impact factor: 4.709

Review 8.  Circulating membrane-derived microvesicles in redox biology.

Authors:  Michael Craig Larson; Cheryl A Hillery; Neil Hogg
Journal:  Free Radic Biol Med       Date:  2014-04-18       Impact factor: 7.376

Review 9.  Emission of membrane vesicles: roles in complement resistance, immunity and cancer.

Authors:  David Pilzer; Olivier Gasser; Oren Moskovich; Jurg A Schifferli; Zvi Fishelson
Journal:  Springer Semin Immunopathol       Date:  2005-11-11

10.  Time courses and value of circulating microparticles in patients with operable stage non-small cell lung cancer undergoing surgical intervention.

Authors:  Chia-Cheng Tseng; Chin-Chou Wang; Chang-Chun Hsiao; Hung-I Lu; Steve Leu; Huang-Chih Chang; Kuo-Tung Huang; Wen-Feng Fang; Yu-Mu Chen; Shih-Feng Liu; Cheng-Ta Yang; Meng-Chih Lin; Hon-Kan Yip
Journal:  Tumour Biol       Date:  2016-04-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.